Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Thermo Fisher Scientific Inc. (TMO)

336.06   -3.68 (-1.08%) 02-20 16:01
Open: 340 Pre. Close: 339.74
High: 341.35 Low: 333.2
Volume: 1,498,677 Market Cap: 134757M
Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 341.852 - 343.575 343.575 - 344.992
Low: 329.235 - 331.051 331.051 - 332.544
Close: 333.395 - 336.246 336.246 - 338.591

Technical analysis

as of: 2020-02-20 4:44:18 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 399.76     One year: 466.92
Support: Support1: 322.89    Support2: 310.92
Resistance: Resistance1: 342.26    Resistance2: 399.76
Pivot: 330.82
Moving Average: MA(5): 337.59     MA(20): 331.47
MA(100): 312.55     MA(250): 291.55
MACD: MACD(12,26): 2.77     Signal(9): 2.16
Stochastic oscillator: %K(14,3): 88.89     %D(3): 89.91
RSI: RSI(14): 54.69
52-week: High: 342.26  Low: 246.67  Change(%): 33.3
Average Vol(K): 3-Month: 131074  10-Days: 159302

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
TMO has closed below upper band by 33.5%. Bollinger Bands are 51.8% wider than normal. The large width of the bands suggest high volatility as compared to TMO's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Global Forecast to 2027 for the Non-Invasive Prenatal Testing (NIPT) Market - Featuring Illumina, Thermo Fisher Scientific, Agilent Technologies & GE Healthcare Among Others -
DUBLIN--(BUSINESS WIRE)--The "Non-Invasive Prenatal Testing (NIPT) Market by Product and Solution (Consumables, Systems, Software), Method (Ultrasound Screening, Cell Free DNA Test), Application (Trisomy, Microdeletions, Monosomy), and End-user (Diagnostic Labs) - Global Forecast to 2027" report has been added to's offering. The Global Non-Invasive Prenatal Testing (NIPT) Market is expected to grow at a CAGR of 17.1% from 2019 to 2027 to reach $13.1 billion by 2027. The g

Thermo Fisher Scientific's Advanced Analytical Instruments Recognized Through Respected Industry Awards
SAN JOSE, Calif., Feb. 17, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced that several of its analytical instruments and solutions have received industry recognition through multiple respected awards. These award-wining analytical…

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M) 400.99
Shares Float (M) 398.06
% Held by Insiders 0.21
% Held by Institutions 91.86
Shares Short (K) 3550
Shares Short P. Month (K)

Stock Financials

EPS 9.170
Book Value (p.s.) 74.370
PEG Ratio 2.01
Profit Margin 14.47
Operating Margin 16.67
Return on Assets (ttm) 4.7
Return on Equity (ttm) 12.9
Qtrly Rev. Growth 4.9
Gross Profit (p.s.) 29.527
Sales Per Share
EBITDA (p.s.) 16.285
Qtrly Earnings Growth 11.60
Operating Cash Flow (M) 4970.00
Levered Free Cash Flow (M) 3290.00

Stock Valuations

P/E 36.65
P/E Growth Ratio -0.01
P/BV 4.52
P/S 5.26
P/CF 27.11

Dividends & Splits

Dividend 0.760
Dividend Yield
Dividend Pay Date 2020-01-14
Ex-Dividend Date 2019-12-15
Forward Dividend 0.760
Last Split Date
Last Split Ratio 1.5
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.